Contracts Finder

NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

NHS England

Awarded

goods

SME-friendly

Framework agreement

This tender has closed

The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.

Key details

Contracting authority

NHS England

nhs

Region

Runcorn

Sector

Healthcare & Medical

Contract value

£580,156,000ex VAT

Submissions closed

22 November 2023

Published

26 February 2024

Procurement

Contract period

1 March 2024 - 31 August 2026

2 years

Procedure type

Open procedure (above threshold)

CPV classifications

33600000 Pharmaceutical products

What happened

Description

Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024

Offer reference number: CM/PHR/22/5678

CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 12 months

Awarded suppliers (39)

Suppliers

Zentiva Pharma UK Ltd
GlaxoSmithKline UK Limited
Celltrion Healthcare United Kingdom Limited
Biogen
Kent Pharma Ltd
Amgen Ltd
Merck Sharpe & Dohme (UK) Limited
Accord-UK Ltd
Neon Healthcare Ltd
Dr.Reddy's Laboratories (UK) Limited
Pfizer Ltd
Bayer Plc
Sandoz Ltd
Aventis Pharma ltd t/a Sanofi
Vifor Pharma UK Ltd
Chugai Pharma UK Ltd
Sun Pharma UK Ltd
Sobi (Swedish Orphan Biovitrum Ltd)
Mylan
Galapagos Biotech Ltd
Abbvie Ltd
Thornton and Ross Ltd
Merck Serono Limited
AstraZeneca
Janssen-Cilag Ltd
Eli Lilly & Company Ltd
Roche Products Ltd
Ipsen
Organon Pharmaceuticals UK Ltd
Almirall
Merz
Napp Pharmaceuticals Ltd
CST Pharma Limited
Pharmacosmos UK Ltd
Orifarm UK
Teva UK Limited
Novo Nordisk
Novartis Pharmaceuticals UK Ltd
Gedeon Richter UK Ltd

Award value

£688,010,000

Award date

26 January 2024

Contact

Address

Rutland House, Runcorn, WA7 2ES

Contact name

Katie Noonan

[email protected]

Identifiers

Buyer reference

CF-2202100D0O000000rwimUAA

Notice ID

c7b18c5b-1199-4503-86c0-f922d2e06c42-726527

OCID

ocds-b5fd17-9914c3d5-bf44-4fbc-a2e3-258a048efd52

Explore related tenders

Other tenders from NHS England

View all →

Secondary Care Medicines Data Pre-Market Engagement£6,750,000

Quality Assurance & Improvement of Structured Learning Placement (SLP) Modules£98,000

Targeted Prostate Cancer Screening Programme - MRI Reporting Service

Targeted Prostate Cancer Screening Programme – PSA Laboratory Processing Service

Strengthening Cultural Capability and Trauma Informed Care in Women’s Health£175,000

External ID: cf-ocds-b5fd17-9914c3d5-bf44-4fbc-a2e3-258a048efd52 • Added 3 October 2026